April 27, 2018 / 1:12 PM / in 3 months

BRIEF-Spring Bank Pharmaceuticals Says Net Loss For Three Months Ended March 31, 2018 Was $4.9 Mln, Or $0.37 Per Share

April 27 (Reuters) - Spring Bank Pharmaceuticals Inc :

* SPRING BANK PHARMACEUTICALS INC - NET LOSS FOR THREE MONTHS ENDED MARCH 31, 2018 WAS $4.9 MILLION, OR $0.37 PER SHARE

* SPRING BANK PHARMACEUTICALS - ANTICIPATES THAT EXISTING CASH, CASH EQUIVALENTS WILL ENABLE CO TO FUND OPERATING EXPENSES & CAPEX REQUIREMENTS INTO Q4 2019

* SPRING BANK PHARMA - ANTICIPATES THAT EXISTING CASH, CASH EQUIVALENTS WILL NOT BE SUFFICIENT TO FUND INITIATION OF ANY PHASE 3 TRIAL FOR INARIGIVIR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below